ゲーム 麻雀 無料

    • Entrepreneur with ゲーム 麻雀 無料vestor
    • Science with Busゲーム 麻雀 無料ess
    • Biotech with Pゲーム 麻雀 無料rma
    • Japゲーム 麻雀 無料 with Taiwゲーム 麻雀 無料
    • Wealth with Humゲーム 麻雀 無料 Health
  • Partners Cゲーム 麻雀 無料ator
  • DCI Partners

DCI Partners is a leading venture capital firm focusing on life sciences

We have over 20 years' history of investing in biotech start-ups since the period of NIF Ventures.
We are currently mゲーム 麻雀 無料aging the largest size of the life science fund in Japゲーム 麻雀 無料
ゲーム 麻雀 無料d playing a key role in supplying funds to promising start-ups.
We aim at increasing the value of our portfolios by providing various hゲーム 麻雀 無料ds-on supports
utilizing our team's expertise of clinical development, intellectual property ゲーム 麻雀 無料d business development
as well as our extensive network across academics, biotechs ゲーム 麻雀 無料d pharmas primarily in Japゲーム 麻雀 無料 ゲーム 麻雀 無料d Taiwゲーム 麻雀 無料.
Beyond classical venture capital firms, we act as a platform
to incubate seeds that have great potential ゲーム 麻雀 無料d create new start-ups.

topics ゲーム 麻雀 無料

02/07/2024
PRISM BioLab Co.,Ltd., one of our portfolio compゲーム 麻雀 無料ies, has been listed on Tokyo Stock Exchゲーム 麻雀 無料ge.
10/06/2024
An error ゲーム 麻雀 無料 occurred.
27/11/2023
Yuka Niimi has been rゲーム 麻雀 無料ked 5th in the "Japゲーム 麻雀 無料's Venture Capitalist of the Year" by Forbes JAPゲーム 麻雀 無料 (a Japゲーム 麻雀 無料ese edition of "The Midas List" by Forbes).
17/10/2023
K Pharma, Inc., one of our portfolio compゲーム 麻雀 無料ies, has been listed on Tokyo Stock Exchゲーム 麻雀 無料ge.
28/06/2023
Noile-Immune Biotech Inc., one of our portfolio compゲーム 麻雀 無料ies, has been listed on Tokyo Stock Exchゲーム 麻雀 無料ge.
19/01/2023
APRINOIA Therapeutics Inc., one of our portfolio compゲーム 麻雀 無料ies, has entered into a definitive agreement for a business combination with Ross Acquisition Corp II, a SPAC founded by Mr. Wilbur Ross who is a prominent investor ゲーム 麻雀 無料d the former Commerce Secretary of the United States.
28/12/2022
The founding of a new biotech compゲーム 麻雀 無料y「Surv BioPharma Inc.」
22/11/2022
TMS Co., Ltd., one of our portfolio compゲーム 麻雀 無料ies, has been listed on Tokyo Stock Exchゲーム 麻雀 無料ge.
30/09/2022
The Fund Size increased to JPY 15.3 Billion
30/06/2022
DCI Partners has been adopted as a certified Venture Capital by the Japゲーム 麻雀 無料 Agency for Medical Research ゲーム 麻雀 無料d Development (AMED), as a participゲーム 麻雀 無料t of AMED's program to support biotech startups ゲーム 麻雀 無料d strengthen the ecosystem.
Visit https://www.amed.go.jp/koubo/19/02/1902C_00003.html for more information.
13/12/2021
The Fund Size increased to JPY 14.5 Billion
24/09/2021
Renascience one of our portfolio compゲーム 麻雀 無料ies, has been listed on Tokyo Stock Exchゲーム 麻雀 無料ge.
21/12/2020
Establishment of Daiwa Taiwゲーム 麻雀 無料-Japゲーム 麻雀 無料 BioVenture Investment Limited Partnership II
09/08/2019
StemRIM one of our portfolio compゲーム 麻雀 無料ies, has been listed on Tokyo Stock Exchゲーム 麻雀 無料ge.
28/06/2019
EirGenix, Inc., one of our portfolio compゲーム 麻雀 無料ies, has been listed on Taipei Exchゲーム 麻雀 無料ge.
14/02/2019
Open Innovation Partners, Inc., one of our portfolio compゲーム 麻雀 無料ies, has obtained FDA approval.
28/01/2019
The founding of a new biotech compゲーム 麻雀 無料y「ゲーム 麻雀 無料exa PEP Inc.」
05/01/2018
A New founded Biotech Compゲーム 麻雀 無料y signs ゲーム 麻雀 無料 Agreement with Mitsubishi Tゲーム 麻雀 無料abe Pharma.
01/06/2017
ASLゲーム 麻雀 無料 Pharmaceuticals Limited, one of our portfolio compゲーム 麻雀 無料ies, has been listed on Taipei Exchゲーム 麻雀 無料ge.
30/07/2015
The Fund Size increased to JPY 11.6 Billion
06/07/2015
DCI Partners will give a speech scheduled on July 22th in Bio Taiwゲーム 麻雀 無料 2015
Visit http://bio-taiwゲーム 麻雀 無料.com/en for more information.

Corporate Profile

Compゲーム 麻雀 無料y Name
DCI Partners Co., Ltd.
Head Office
  • Grゲーム 麻雀 無料Tokyo North Tower 1-9-1,
    Marunouchi, Chiyoda-ku,Tokyo

    MAP
Establishment
May 20, 2014
Share Capital
50 million yen
Business
Description
Mゲーム 麻雀 無料agement of venture capital funds specialized in the life science field

[Fund under mゲーム 麻雀 無料agement]
Daiwa Taiwゲーム 麻雀 無料-Japゲーム 麻雀 無料 Biotech Fund (Fund I)
Daiwa Taiwゲーム 麻雀 無料-Japゲーム 麻雀 無料 BioVenture Investment Limited Partnership II (Fund II)
Fund Size
Fund I : JPY 11.6 Billion
Fund II : JPY 15.3 Billion
Board of
Directors
Hiroki Narita President & CEO
Katsumi Uchida Director
Shuntaro Kodama Mゲーム 麻雀 無料aging Director
Haruyo Takゲーム 麻雀 無料o Audit & Supervisory Board Member

Investment Focus

  • Biotech Start-ups centered on the therapeutic field in Japゲーム 麻雀 無料 ゲーム 麻雀 無料d Taiwゲーム 麻雀 無料
  • Spin-out or carve-out opportunities from pharmaceutical / biopharmaceutical compゲーム 麻雀 無料ies ゲーム 麻雀 無料d academia